13D Filing: Junwei Zheng and Kiwa Bio-Tech Products Group Corp

Page 4 of 5 – SEC Filing

 

Item
5. Interest in Securities of the Issuer.

 

(a)       As
of the date hereof, Mr. Zheng beneficially
owns 920,000 shares of the issued and outstanding common stock of the Company. Such
amount represents 9.58% of the total issued and outstanding shares of the Company’s
common stock as of the date hereof.

 

(b)        Mr. Zheng holds sole voting and dispositive power over the Shares.

 

(c)       Other
than disclosed below,
there were no transactions by Mr. Zheng
in the Issuer’s Common Stock during the last 60 days:

 

None.

 

(d)       No
other person is known to have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from
the sale of, the securities of the Issuer owned by Mr. Zheng.

 

(e)        Not applicable.

 

Item
6. Contracts, Agreements, Understandings or Relationships With
Respect to Securities of the Issuer.

 

To
the knowledge of Mr.
Zheng, there are no contracts,
arrangements, understandings or relationships (legal or otherwise), including but not limited to transfer or voting of any of
the securities, finder’s fees, joint ventures, loan or option arrangements,
puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies between Mr.
Zheng and/or any other person, with respect to any securities of the Company.

 

Item
7. Material to be Filed as Exhibits.

 

Not
applicable.

 

Follow Kiwa Bio-Tech Products Group Corp